On Tuesday, Mimedx Group Inc (NASDAQ: MDXG) opened higher 4.24% from the last session, before settling in for the closing price of $7.79. Price fluctuations for MDXG have ranged from $5.47 to $10.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 3.85% over the past five years. Company’s average yearly earnings per share was noted -2.86% at the time writing. With a float of $115.66 million, this company’s outstanding shares have now reached $146.93 million.
Let’s look at the performance matrix of the company that is accounted for 837 employees. In terms of profitability, gross margin is 82.67%, operating margin of 16.89%, and the pretax margin is 16.42%.
Mimedx Group Inc (MDXG) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mimedx Group Inc is 21.51%, while institutional ownership is 49.82%. The most recent insider transaction that took place on Mar 10 ’25, was worth 646,681. Before that another transaction happened on Feb 28 ’25, when Company’s Chief Commercial Officer sold 2,111 for $8.40, making the entire transaction worth $17,743. This insider now owns 265,271 shares in total.
Mimedx Group Inc (MDXG) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.86% per share during the next fiscal year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Check out the current performance indicators for Mimedx Group Inc (MDXG). In the past quarter, the stock posted a quick ratio of 3.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.43. Likewise, its price to free cash flow for the trailing twelve months is 18.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.28, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of Mimedx Group Inc (MDXG)
Mimedx Group Inc (NASDAQ: MDXG) saw its 5-day average volume 0.65 million, a positive change from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 51.46%. Additionally, its Average True Range was 0.31.
During the past 100 days, Mimedx Group Inc’s (MDXG) raw stochastic average was set at 55.65%, which indicates a significant decrease from 68.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.73% in the past 14 days, which was lower than the 52.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.58, while its 200-day Moving Average is $7.49. Nevertheless, the first resistance level for the watch stands at $8.30 in the near term. At $8.48, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.77. If the price goes on to break the first support level at $7.83, it is likely to go to the next support level at $7.54. Assuming the price breaks the second support level, the third support level stands at $7.36.
Mimedx Group Inc (NASDAQ: MDXG) Key Stats
There are currently 147,366K shares outstanding in the company with a market cap of 1.20 billion. Presently, the company’s annual sales total 348,880 K according to its annual income of 42,420 K. Last quarter, the company’s sales amounted to 92,910 K and its income totaled 7,440 K.
